share_log

Ensysce Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Matthews Lane Capital Partners LLC(7.9%),Daniel B. Silvers(7.9%), etc.

Ensysce Biosciences | SC 13D/A:超過5%持股股東披露文件(修正)-Matthews Lane Capital Partners LLC(7.9%),Daniel B. Silvers(7.9%)等

2022/07/07 09:08
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息